• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ALK-Abello A/S

+ Add to Watchlist

AKABY:US

Snapshot for ALK-Abello A/S (AKABY)

Open: - Day's Range: - Volume: 0
Previous Close: 30.2000 52wk Range: 30.2000 - 30.2000 1-Yr Rtn: -

Stock Chart for AKABY

No chart data available.
  • AKABY:US 30.2000
  • 1M
  • 1Y
30.2000
Interactive AKABY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKABY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 1,252.95
Shares Outstanding (M) 46.04
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKABY

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for AKABY

Alk-Abello A/S produces pharmaceuticals for allergy vaccination. The Company is an international group with subsidiaries and associated companies worldwide.

Jens BagerPresident/CEOSoren NiegelExec VP:Commercial Operations
Flemming PedersenExec VP:Finance & IT/CFOHenrik JacobiExec VP:Research & Dev
More Company Profile & Key Executives for AKABY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil